Optovue, an ocular disease treatment co., raises $10.5M

Entities Mentioned

• Optovue
• Jay Wei

1. Optovue, a Fremont, Ca. maker of devices that improve diagnosis and treatment of ocular disease, has received $10.5 million in second round of funding, the company announced said.
   
   Based on high speed and high resolution Fourier-Domain OCT technology, the products help with retina conditions such as macular degeneration, diabetic retinopathy, glaucoma, and other macular diseases.
   
   Trevi Health Ventures led the round, which also included Acorn Campus Ventures, HNQ Asia Pacific, Harbinger Venture Management, iD SoftCapital and other individual investors. Optovue raised about $4.5 million in a first round (Read Full Article)
   
   

   Related Articles

   • Three dimensional tracking for volumetric spectral-domain optical coherence tomography
   • also categorized in Ophthalmology
   • Optovue Receives FDA Clearance for Cornea/Anterior Module for RTVue
   • also mentions Optovue
   • Optical coherence tomography evaluation of posterior capsule opacification related to intraocular lens design
   • also categorized in Ophthalmology
   • Advances in the diagnosis and immunotherapy for ocular inflammatory disease.
   • also categorized in Ophthalmology
   • The stress on the anterior lens surface during human in vivo accommodation
   • also categorized in Ophthalmology

   • Retinal blood flow measurement by using optical coherence tomography
   • also categorized in Ophthalmology
   • Advances in the diagnosis and immunotherapy for ocular inflammatory disease
   • also categorized in Ophthalmology
   • Optovue Fastest Growing Ophthalmic Device Company in Eye Care
   • also mentions Jay Wei
   • Three-Dimensional Evaluation of Vitreomacular Traction and Epiretinal Membrane Using Spectral-Domain Optical Coherence Tomography
   • also categorized in Ophthalmology
   • Tools help clinicians identify glaucoma progression
   • also categorized in Ophthalmology

Login to comment.